Počet záznamů: 1
Novel Bradykinin Analogues Modified in the N-Terminal Part of the Molecule with a Variety of Acyl Substituents
- 1.
SYSNO ASEP 0377892 Druh ASEP J - Článek v odborném periodiku Zařazení RIV J - Článek v odborném periodiku Poddruh J Článek ve WOS Název Novel Bradykinin Analogues Modified in the N-Terminal Part of the Molecule with a Variety of Acyl Substituents Tvůrce(i) Sleszynska, M. (PL)
Wierzba, T. H. (PL)
Malinowski, K. (PL)
Tůmová, Tereza (UOCHB-X) RID
Lammek, B. (PL)
Slaninová, Jiřina (UOCHB-X)
Prahl, A. (PL)Celkový počet autorů 7 Zdroj.dok. International Journal of Peptide Research and Therapeutics - ISSN 1573-3149
Roč. 18, č. 2 (2012), s. 117-124Poč.str. 8 s. Jazyk dok. eng - angličtina Země vyd. US - Spojené státy americké Klíč. slova bradykinin analogues ; B-2 receptor antagonists ; bulky acyl groups ; in vivo rat blood pressure test ; in vitro rat uterus test Vědní obor RIV CE - Biochemie CEZ AV0Z40550506 - UOCHB-X (2005-2011) UT WOS 000303453500004 DOI 10.1007/s10989-011-9285-5 Anotace In the current work we present some pharmacological characteristics of ten new analogues of bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg) modified in the N-terminal part of the molecule with a variety of acyl substituents. Of the many acylating agents used previously with B-2 receptor antagonists, the following residues were chosen: 1-adamantaneacetic acid (Aaa), 1-adamantanecarboxylic acid (Aca), 4-tert-butylbenzoic acid (t-Bba), 4-aminobenzoic acid (Aba), 12-aminododecanoic acid (Adc), succinic acid (Sua), 4-hydroxybenzoic acid, 4-hydroxy-3-methoxybenzoic acid, 3-(4-hydroxyphenyl)propionic acid and 6-hydroxy-2-naphthoic acid. Biological activity of the compounds was assessed in the in vivo rat blood pressure test and the in vitro rat uterus test. Surprisingly, N-terminal substitution of the bradykinin peptide chain itself with aforementioned groups resulted in antagonists of bradykinin in the pressor test and suppressed agonistic potency in the uterotonic test. These interesting findings need further studies as they can be helpful for designing more potent B-2 receptor blockers. Pracoviště Ústav organické chemie a biochemie Kontakt asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434 Rok sběru 2013
Počet záznamů: 1